Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/108900
Título: | Recombinant pre-miR-29b for Alzheimer´s disease therapeutics | Autor: | Pereira, Patrícia A Tomás, Joana F Queiroz, João A Figueiras, Ana R. Sousa, Fani |
Data: | 28-Jan-2016 | Editora: | Springer Nature | Título da revista, periódico, livro ou evento: | Scientific Reports | Volume: | 6 | Número: | 1 | Resumo: | MicroRNAs are arising as the next generation of diagnostic and therapeutic tools for gene silencing. Studies demonstrated that the miR-29 expression is decreased in Alzheimer's disease (AD) patients displaying high levels of human β-secretase (hBACE1). Recent advances toward an effective therapy for AD intend to employ miR-29 to suppress hBACE1 expression and subsequent Amyloid-β (Aβ) peptide. However, delivery of mature miRNA has demonstrated modest efficacy in vitro; therefore, the preparation of highly pure and biologically active pre-miRNA arises as one of the most important challenges in the development of these therapeutic strategies. Recently, we described a new strategy based arginine-affinity chromatography to specifically purify the recombinant pre-miR-29b. Following this strategy, the purified pre-miR-29b was successfully encapsulated into polyplexes that were further delivered in cytoplasm. It was verified that Chitosan/pre-miR-29b and Polyethylenimine/pre-miR-29b systems efficiently delivered pre-miR-29b to N2a695 cells, thus reducing the hBACE1 protein expression (around 78% and 86%, respectively) and Aβ42 levels (approximately 44% and 47%, respectively). Furthermore, pre-miR-29b downregulates the hBACE1 mRNA expression in 80%. Overall, it was demonstrated that the recombinant pre-miR-29b using polyplexes allowed to decrease the hBACE1 and Aβ42 expression levels, improving the currently available methodologies of miRNA-based therapeutics. | URI: | https://hdl.handle.net/10316/108900 | ISSN: | 2045-2322 | DOI: | 10.1038/srep19946 | Direitos: | openAccess |
Aparece nas coleções: | I&D CNC - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Recombinant-premiR29b-for-Alzheimers-disease-therapeuticsScientific-Reports.pdf | 2.73 MB | Adobe PDF | Ver/Abrir |
Visualizações de página
59
Visto em 8/mai/2024
Downloads
11
Visto em 8/mai/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons